These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2439658)

  • 1. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.
    Hartmann HA
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):507. PubMed ID: 2439658
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
    Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE
    Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.
    Kril JJ; Patel S; Harding AJ; Halliday GM
    Acta Neuropathol; 2002 Apr; 103(4):370-6. PubMed ID: 11904757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.
    Velez-Pardo C; Arellano JI; Cardona-Gomez P; Jimenez Del Rio M; Lopera F; De Felipe J
    Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms.
    Hol EM; Roelofs RF; Moraal E; Sonnemans MA; Sluijs JA; Proper EA; de Graan PN; Fischer DF; van Leeuwen FW
    Mol Psychiatry; 2003 Sep; 8(9):786-96. PubMed ID: 12931206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.
    Nunomura A; Chiba S; Lippa CF; Cras P; Kalaria RN; Takeda A; Honda K; Smith MA; Perry G
    Neurobiol Dis; 2004 Oct; 17(1):108-13. PubMed ID: 15350971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
    Raina AK; Zhu X; Shimohama S; Perry G; Smith MA
    Cell Biochem Biophys; 2003; 39(3):249-55. PubMed ID: 14716079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease.
    Rössler M; Zarski R; Bohl J; Ohm TG
    Acta Neuropathol; 2002 Apr; 103(4):363-9. PubMed ID: 11904756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
    Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.
    Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K
    Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease.
    von Gunten A; Kövari E; Bussière T; Rivara CB; Gold G; Bouras C; Hof PR; Giannakopoulos P
    Neurobiol Aging; 2006 Feb; 27(2):270-7. PubMed ID: 16399212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD; Ermak G; Davies KJ
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
    Gómez-Isla T; Hollister R; West H; Mui S; Growdon JH; Petersen RC; Parisi JE; Hyman BT
    Ann Neurol; 1997 Jan; 41(1):17-24. PubMed ID: 9005861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
    Zhu X; McShea A; Harris PL; Raina AK; Castellani RJ; Funk JO; Shah S; Atwood C; Bowen R; Bowser R; Morelli L; Perry G; Smith MA
    J Neurosci Res; 2004 Mar; 75(5):698-703. PubMed ID: 14991845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease.
    Diarra A; Geetha T; Potter P; Babu JR
    Biochem Biophys Res Commun; 2009 Dec; 390(3):352-6. PubMed ID: 19818333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation.
    Braak H; Del Tredici K
    Neurobiol Aging; 2004 Jul; 25(6):713-8; discussion 743-6. PubMed ID: 15165692
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.
    Woodhouse A; Vickers JC; Dickson TC
    Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary results of the study of neuronal death and the expression of bcl-2 protein in Alzheimer's disease].
    Erro E; Tuñón T
    Rev Med Univ Navarra; 1997; 41(1):28-33. PubMed ID: 9580053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease.
    Baig S; Wilcock GK; Love S
    Acta Neuropathol; 2005 Oct; 110(4):393-401. PubMed ID: 16133543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.